Sponsor

National Institute on Drug Abuse (NIDA)

Clinical research sponsor

Published trials570
Recruiting shown24
Roles2
SourceClinicalTrials.gov

Clinical trials

60 shown
Defining Neurobiological Links Between Substance Use and Mental IllnessNCT05538910 · lead sponsor · 2023-02-02
RECRUITING
Olfactory Function and Model-Based Behavior in People Living With HIV and SUDNCT07637669 · lead sponsor · 2026-10-12
NOT_YET_RECRUITING
Health Outcomes by Neighborhood - BaltimoreNCT01571752 · lead sponsor · 2012-07-17
COMPLETED
Brain Functions Underlying Visuospatial Attention Deficits in SchizophreniaNCT01399437 · lead sponsor · 2011-07-03
COMPLETED
Brain Circuits in Schizophrenia and SmokingNCT01369966 · lead sponsor · 2011-05-16
COMPLETED
Nicotinic Receptor Density in Smoking and Nonsmoking SchizophrenicsNCT01246128 · lead sponsor · 2010-10-31
WITHDRAWN
Effects of Antipsychotics on Eating and Food Craving in People With SchizophreniaNCT01222793 · lead sponsor · 2010-09-26
COMPLETED
Assessment of Cannabis Craving in Schizophrenia Using Virtual RealityNCT01212081 · lead sponsor · 2010-09-26
COMPLETED
Risk Perception in Drug-Dependent Adults With and Without SchizophreniaNCT01031563 · lead sponsor · 2009-08-18
COMPLETED
Assessment of Craving in Nicotine-Dependent Patients With Schizophrenia Using Virtual RealityNCT01031433 · lead sponsor · 2009-07-28
COMPLETED
Effects of Nicotine on Areas of Impaired and Preserved Functioning in SchizophreniaNCT01034085 · lead sponsor · 2009-06-02
COMPLETED
Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance PatientsNCT00780702 · lead sponsor · 2008-05-08
COMPLETED
Multi-Level HIV Prevention for Pregnant Drug AbusersNCT01976702 · lead sponsor · 2006-10-01
COMPLETED
The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215NCT01034800 · lead sponsor · 2006-09-01
COMPLETED
Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug DependenceNCT01037075 · lead sponsor · 2006-05-14
COMPLETED
Neuroimaging Studies of Neurophysiological Phenotypes in SchizophreniaNCT01036568 · lead sponsor · 2006-02-14
COMPLETED
Assessing the Variability Over Time of Tobacco Carcinogen Biomarkers in Smokers - 2NCT00158145 · lead sponsor · 2005-09-01
COMPLETED
Dopamine Function and Reward Processing In SchizophreniaNCT01035996 · lead sponsor · 2005-03-08
COMPLETED
fMRI Study of Nicotinic Effect on Neurophysiology of SchizophreniaNCT01046526 · lead sponsor · 2005-02-08
COMPLETED
Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency ManagementNCT00292110 · lead sponsor · 2004-02-01
COMPLETED
Effect of Bupropion on Smoking Behavior in Smokers With SchizophreniaNCT00218231 · lead sponsor · 2004-01-01
COMPLETED
Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1NCT00218556 · lead sponsor · 2004-01-01
COMPLETED
An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug UsersNCT00841477 · lead sponsor · 2004-01-01
COMPLETED
Positive Choice: Prevention for Positive HealthNCT00447707 · lead sponsor · 2003-12-01
COMPLETED
Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2NCT00135772 · lead sponsor · 2003-10-01
COMPLETED
Chronic Hepatitis Intervention Project for Drug UsersNCT00596843 · lead sponsor · 2003-09-01
COMPLETED
Physician Focused Intervention to Improve Adherence With HIV AntiretroviralsNCT00870792 · lead sponsor · 2002-11-01
COMPLETED
Study to Reduce Intravenous Exposures (STRIVE)NCT00391482 · lead sponsor · 2002-06-01
COMPLETED
Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With SchizophreniaNCT00218218 · lead sponsor · 2002-06-01
COMPLETED
The Aim of This Study is to Determine the Effectiveness of a Motivational Enhancement Intervention in Reducing Risk Behaviors (Drug and Alcohol Use, Sexual Risk Behavior, Poor Adherence to Medications) Among HIV+ Youth. - 1NCT00227825 · lead sponsor · 2002-01-01
UNKNOWN
Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDSNCT00079560 · lead sponsor · 2001-12-01
COMPLETED
Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1NCT00124683 · lead sponsor · 2001-09-01
COMPLETED
Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1NCT00046813 · lead sponsor · 2001-08-01
TERMINATED
Integrated Treatment for Cocaine and Mood Disorders - 1NCT00227812 · lead sponsor · 2001-04-01
COMPLETED
Cognitive Behavioral Stress Management for HIV+ Drug AbusersNCT00722644 · lead sponsor · 1999-09-01
COMPLETED
Motivation and Patch Treatment for HIV-positive SmokersNCT00551720 · lead sponsor · 1999-01-01
COMPLETED
Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who SmokeNCT00307203 · lead sponsor · 1998-08-01
COMPLETED
Project SHIELD 2.0: Police Education to Support Public Health in KentuckyNCT07804121 · collaborator · 2026-06-25
RECRUITING
CHAMPION: Combining HIV And Meth Prevention and Treatment Interventions Optimized for HIV-Negative MSMNCT07213258 · collaborator · 2026-04-24
RECRUITING
The Trans-Led Care StudyNCT06880705 · collaborator · 2026-04-14
RECRUITING
Mindfulness Training During Accelerated TMS for DepressionNCT07369557 · collaborator · 2026-04-13
RECRUITING
Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis UseNCT06878859 · collaborator · 2026-02-23
RECRUITING
Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical TrialNCT07125235 · collaborator · 2026-02-09
RECRUITING
HIV, Equity, and Addiction Training (HEAT) ProgramNCT06370481 · collaborator · 2026-01-29
RECRUITING
Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy VolunteersNCT07349758 · collaborator · 2026-01-06
RECRUITING
California MEPS HubNCT07433985 · collaborator · 2025-12-01
RECRUITING
Shared Decision Making to Treat Or Prevent (STOP) HIV in Criminal Legal Involved Populations (R33)NCT07223398 · collaborator · 2025-11-24
RECRUITING
Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young AdultsNCT06444360 · collaborator · 2025-11-04
RECRUITING
Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service ImplementationNCT06103370 · collaborator · 2025-10-28
RECRUITING
Feasibility of Internet-based HIV Prevention ResearchNCT07625917 · collaborator · 2025-08-01
RECRUITING
Project Vuselela FeasibilityNCT07117656 · collaborator · 2025-07-13
RECRUITING
Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)NCT06730555 · collaborator · 2025-06-27
RECRUITING
Project neuroARTEMISNCT06814275 · collaborator · 2025-04-29
RECRUITING
Naltrexone for Overdose PreventionNCT06633900 · collaborator · 2025-04-10
RECRUITING
Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug UseNCT06829238 · collaborator · 2025-04-07
RECRUITING
Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use DisordersNCT05934305 · collaborator · 2025-03-12
RECRUITING
reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)NCT05958017 · collaborator · 2025-03-04
RECRUITING
Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority IndividualsNCT06745947 · collaborator · 2025-03-03
RECRUITING
Vaping and Smoking Project in People With SchizophreniaNCT06944847 · collaborator · 2025-02-15
RECRUITING
Stress and Pain in People Living With HIVNCT06784908 · collaborator · 2025-01-16
RECRUITING

Sponsor roles

collaborator533
lead sponsor37

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.